Dexlansoprazole API Market, Global Outlook and Forecast 2023-2030
Dexlansoprazole is used to heal and maintain healing of?erosive esophagitis?and to treat?heartburn?associated with?gastroesophageal reflux disease?(GERD).?It lasts longer than?lansoprazole, to which it is chemically related, and needs to be taken less often.?There is no good evidence that it works better than other PPIs.
This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole API. This report contains market size and forecasts of Dexlansoprazole API in global, including the following market information:
Global Dexlansoprazole API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Dexlansoprazole API Market Sales, 2018-2023, 2024-2030, (Ton)
Global top five Dexlansoprazole API companies in 2022 (%)
The global Dexlansoprazole API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dexlansoprazole API include Piramal Enterprises Limited, Metrochem API Private Limited, Zhejiang Hengkang Pharmaceutical, Lupin Ltd, Dipharma, Optimus Pharma P Limited and Orchid Chemicals & Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dexlansoprazole API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dexlansoprazole API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Dexlansoprazole API Market Segment Percentages, by Type, 2022 (%)
Purity?98%
Purity<98%
Global Dexlansoprazole API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Dexlansoprazole API Market Segment Percentages, by Application, 2022 (%)
Dexlansoprazole Capsules
Others
Global Dexlansoprazole API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Dexlansoprazole API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dexlansoprazole API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dexlansoprazole API revenues share in global market, 2022 (%)
Key companies Dexlansoprazole API sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Dexlansoprazole API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Piramal Enterprises Limited
Metrochem API Private Limited
Zhejiang Hengkang Pharmaceutical
Lupin Ltd
Dipharma
Optimus Pharma P Limited
Orchid Chemicals & Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dexlansoprazole API, market overview.
Chapter 2: Global Dexlansoprazole API market size in revenue and volume.
Chapter 3: Detailed analysis of Dexlansoprazole API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dexlansoprazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dexlansoprazole API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
